THE HANKIN GROUPIdera Pharmaceuticals, Inc. • March 7th, 2018 • Biological products, (no disgnostic substances)
This Lease consists of Part I, consisting of Section 1, and Part II, consisting of Sections 2 through 43, and the following exhibits:
SCIENTIFIC ADVISOR AGREEMENTScientific Advisor Agreement • March 7th, 2018 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS SCIENTIFIC ADVISOR AGREEMENT (the “Agreement”) is made and entered into this 1st day of June 2017 (the “Effective Date”) by and between Idera Pharmaceuticals, Inc., having a place of business at 167 Sidney Street, Cambridge, Massachusetts 02139, USA (hereinafter referred to as “Idera”) and Sudhir Agrawal, of Shrewsbury, Massachusetts (hereinafter referred to as the “Advisor”). Idera and Advisor may be referred to herein individually as a “Party” and collectively as the “Parties.”
AMENDMENT TO LEASELease • March 7th, 2018 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
THIS AMENDMENT TO LEASE (“Amendment”) is made this 23rd day of September, 2015 by and between 505 EAGLEVIEW BOULEVARD ASSOCIATES, a Pennsylvania limited partnership (“Landlord”) and IDERA PHARMACEUTICALS, INC., a corporation (“Tenant”).
